Serviços Personalizados
Journal
Artigo
Inglês (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO 
Acessos
Links relacionados
Citado por Google 
Similares em
SciELO 
Similares em Google
Compartilhar
Permalink
Urología Colombiana
versão On-line ISSN 2027-0119
Resumo
GALVIS, Juan C. et al. The role of PET-PSMA in guiding prostate cancer radiation therapy: experience in a salvage and curative setting. Urol. Colomb. [online]. 2023, vol.32, n.2, pp.36-44. Epub 25-Abr-2024. ISSN 2027-0119. https://doi.org/10.24875/ruc.23000005.
Introduction:
The role of positron emission tomography (PET) prostate-specific membrane antigen (PSMA) in guiding radiation therapy treatment plans remains to be defined.
Methods:
We conducted a retrospective observational study of patients with prostate cancer referred for radiotherapy. Our objective was to establish the role of PET-PSMA in decision-making and changes in the radiotherapy treatment plan.
Results:
In the entire cohort, 26.8% had lymph node involvement outside the conventional field. The PET results upstaged and changed radiotherapy treatment plans for 75% in primary radiotherapy and 50% in salvage radiation.
Conclusions:
PET-PSMA changes decision-making and treatment planning for radiotherapy, including treatment volumes not traditionally delimited in contour atlases.
Palavras-chave : Radiation; Radionuclide imaging; Prostate cancer; Prostate-specific membrane antigen; Positron emission tomography/Computerized tomography.
